SG Americas Securities LLC sells 34,156 shares of LifeStance Health Group, Inc. (NASDAQ:LFST)

VaselineAugust 28, 2024

0 4 minutes read

SG Americas Securities LLC reduced its holdings in shares of LifeStance Health Group, Inc. (NASDAQ:LFST – Free Report) by 76.0% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,769 shares of the company’s stock after selling 34,156 shares during the period. SG Americas Securities LLC’s holdings in LifeStance Health Group were worth $53,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in the business. Charles Schwab Investment Management Inc. boosted its holdings in shares of LifeStance Health Group by 0.7% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 744,617 shares of the company’s stock worth $5,830,000 after buying an additional 5,112 shares during the last quarter. Swiss National Bank raised its stake in LifeStance Health Group by 25.4% in the first quarter. Swiss National Bank now owns 186,800 shares of the company’s stock worth $1,153,000 after acquiring an additional 37,800 shares in the last quarter. Brown Advisory Inc. grew its holdings in LifeStance Health Group by 25.9% in the fourth quarter. Brown Advisory Inc. now owns 5,158,980 shares of the company’s stock worth $40,395,000 after buying an additional 1,062,887 shares during the period. Principal Financial Group Inc. grew its holdings in LifeStance Health Group by 2.8% in the fourth quarter. Principal Financial Group Inc. now owns 4,006,344 shares of the company’s stock worth $31,370,000 after purchasing an additional 110,457 shares during the period. Finally, Assetmark Inc. boosted its holdings in shares of LifeStance Health Group by 21.6% during the fourth quarter. Assetmark Inc. now owns 11,895 shares of the company’s stock valued at $93,000 after purchasing an additional 2,114 shares during the period. Institutional investors and hedge funds own 85.50% of the company’s shares.

Changes in Analyst Ratings

Several analysts recently commented on LFST shares. Barclays cut their price target on LifeStance Health Group from $8.00 to $6.00 and set an “underweight” rating for the company in a research note on Friday, August 9th. UBS Group decreased their price objective on LifeStance Health Group from $9.00 to $7.50 and set a “neutral” rating for the company in a research note on Thursday, August 15th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and two have issued a buy rating to the company. The stock has a consensus rating of “Hold” and an average price target of $8.25, according to MarketBeat.

Want more great investment ideas?

Check out the latest stock analysis on LifeStance Health Group

LifeStance Health Group price performance

Shares of LFST stock opened at $6.27 on Wednesday. The company has a debt-to-equity ratio of 0.20, a quick ratio of 1.18, and a current ratio of 1.18. The company has a 50 day simple moving average of $5.49 and a two hundred day simple moving average of $6.06. The company has a market cap of $2.40 billion, a P/E ratio of -13.06 and a beta of 1.20. LifeStance Health Group, Inc. it has a 52 week low of $4.64 and a 52 week high of $9.20.

LifeStance Health Group (NASDAQ:LFST – Get Your Free Report ) last announced its earnings results on Thursday, August 8th. The company reported ($0.06) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.07) by $0.01. The company had revenue of $312.30 million for the quarter, compared to analysts’ expectations of $305.85 million. LifeStance Health Group had a negative return on equity of 11.92% and a negative net margin of 15.69%. LifeStance Health Group’s quarterly revenue was up 20.3% on a year-over-year basis. In the same quarter last year, the company earned ($0.13) earnings per share. Research analysts expect that LifeStance Health Group, Inc. to record -0.25 EPS for the current fiscal year.

Insider Trading at LifeStance Health Group

In other news, insider Ann Varanakis sold 5,269 shares of the stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $6.28, for a total value of $33,089.32. Following the completion of the sale, the insider now owns 263,007 shares in the company, valued at $1,651,683.96. The sale was disclosed in a filing with the SEC, which is accessible through the SEC’s website. In other news, insider Denmark J. Qureshi sold 150,000 shares of the company’s stock in a transaction that occurred on Friday, June 14th. The stock was sold at an average price of $5.21, for a total value of $781,500.00. Following the transaction, the insider now owns 439,002 shares in the company, valued at approximately $2,287,200.42. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Ann Varanakis sold 5,269 shares of the stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $6.28, for a total value of $33,089.32. Following the sale, the insider now directly owns 263,007 shares of the company’s stock, valued at $1,651,683.96. The disclosure for this sale can be found here. Insiders sold a total of 240,362 shares of company stock worth $1,285,154 over the last quarter. 6.60% of shares are currently owned by corporate insiders.

LifeStance Health Group Profile

(Free Report)

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy.